MicroRNA‐21 Expression is regulated by β‐catenin/STAT3 Pathway and Promotes Glioma Cell Invasion by Direct Targeting RECK
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
SUMMARY: Aims: MicroRNA‐21 (miR‐21) expression is increased in many types of human malignancy, including glioma. Recent studies report that miR‐21 regulates cell invasion by targeting RECK, however, the underlying transcriptional regulation of miR‐21 in glioma cells remains elusive. Results: Here, we identify a positive correlation between miR‐21 expression and pathological grade in glioma tissues. We demonstrate that β‐catenin pathway regulates miR‐21 expression in human umbilical vein endothelial cell and glioma cells, and that this regulation is signal transducer and activator of transcription 3 (STAT3)‐dependent. Further, chromatin immunoprecipitation and luciferase reporter analysis demonstrate that miR‐21 is controlled by an upstream promoter containing a conserved STAT3 binding site. Notably, knockdown of miR‐21‐inhibited cell invasion by increasing RECK expression and decreased tumor growth in a xenograft model. Conclusion: These data provide compelling evidence that β‐catenin regulation of miR‐21 via STAT3 plays a role in glioma cell invasion and proliferation and indicate that STAT3 is a potential therapeutic target for glioma intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005 · cited 1×
“For example, Toll ligand receptor activation by LPS upregulates miR-21 in many cells types, including macrophages, fibroblasts, and peripheral blood mononuclear cells [39].”
BackgroundmiR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00479-08 · Cited by 888 · cited 4×
“Reports from our laboratory and others have identified roles for miR-21 in glioma cell apoptosis [28–31], invasion [21], and response to radiotherapy and chemotherapy [32–35], suggesting that miR-21 may be a good target for therapeutic intervention [36–38].”
BackgroundInfluentialMolecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847 · cited 1×
“For this reason, a great deal of research has been devoted to identifying the molecular mechanisms that contribute to malignant progression and invasive growth of glioma [4,5].”
BackgroundMicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705 · cited 1×
“In summary, it has been found that the expression of miR21 was associated with the pathological grade of glioma and the key roles for miR-21 in tumor-related pathways [16,42], apoptosis via PDCD4, caspase 9 and 3 [28–31], invasion via RECK and TIMP [21], chemosensitivity via Bax/Bcl-2 ratio, caspase-3, and LRRFIP1 [32…”
BackgroundLöffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007) · Blood · doi:10.1182/blood-2007-03-081133 · Cited by 637 · cited 7×
“After cross-linking, protein and RNA were removed and the purified DNA was subjected to PCR with primers specific for the miR-21 upstream region containing the STAT3 binding sites, forward: 5′-CCTCTGAGAAGAGGGGACAA-3′, reverse: 5′- ACCGCTTCCAGCAA AAGAGT-3′ [18].”
BackgroundMethodInfluentialStat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1045 · Cited by 406
Malzkorn, B., Wolter, M., Liesenberg, F., Grzendowski, M., Stühler, K., Meyer, H. E., & Reifenberger, G. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00328.x · Cited by 352
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
Chen, Y., Liu, W., Chao, T., Zhang, Y., Yan, X., Gong, Y., Qiang, B., Yuan, J., Sun, M., & Peng, X. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.034 · Cited by 217
Yang, C. H., Yue, J., Fan, M., & Pfeffer, L. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2579 · Cited by 179
Han, L., Yang, Y., Yue, X., Huang, K., Liu, X., Pu, P., Jiang, H., Yan, W., Jiang, T., & Kang, C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.097 · Cited by 57
Self-citation
Cited by
Xu, L.-F., Wu, Z.-P., Chen, Y., Zhu, Q.-S., Hamidi, S., & Navab, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103698 · Cited by 194
“It has been shown that miR-21 modulates cell growth, invasion, and apoptosis by targeting RECK in many cancers, such as oral cancer [51], esophageal cancer [52], prostate cancer [53], and glioma [54], however the relationship between miR-21 and RECK in lung cancer is largely unknown.”
BackgroundShi, Z., Zhang, J., Qian, X., Han, L., Zhang, K., Chen, L., Liu, J., Ren, Y., Yang, M., Zhang, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0280 · Cited by 190
“PTEN, PDCD4, and RECK, which are considered to be associated with tumor cell survival, proliferation, and invasion (37, 38, 20), were upregulated after AC1MMYR2 treatment.”
MethodSelf-citationThe crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer
Peng, Y., Zhang, X., Feng, X., Fan, X., & Jin, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.12923 · Cited by 149
“Similarly, miR-21 is trans-activated by β-catenin in a STAT3 dependent manner to promote cell invasion in glioma [102].”
BackgroundThe role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?
Aloizou, A.-M., Pateraki, G., Siokas, V., Mentis, A.-F. A., Liampas, I., Lazopoulos, G., Kovatsi, L., Mitsias, P. D., Bogdanos, D. P., Paterakis, K., et al. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.11.001 · Cited by 69
MicroRNA-21 expression is associated with overall survival in patients with glioma
Wu, L., Li, G., Feng, D., Qin, H., Gong, L., Zhang, J., & Zhang, Z. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-200 · Cited by 53
Metadata
- Authors
- Han, L., Yue, X., Zhou, X., Lan, F., You, G., Zhang, W., Zhang, K., Zhang, C., Cheng, J., Yu, S., Pu, P., Jiang, T., & Kang, C.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2012-05-28
- Volume
- 18
- Issue
- 7
- Pages
- 573-583
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W1566823022
- Cited by
- 103
- References
- 13
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.